Saudi Arabia Molecular Cytogenetics Market Size & Outlook, 2028

Revenue, 2020 (US$M)

$10.5

Forecast, 2028 (US$M)

$22.0

CAGR, 2021 - 2028

9.7%

Report Coverage

Saudi Arabia

Saudi Arabia molecular cytogenetics market, 2018-2028 (US$M)

Related Markets

Global Molecular Cytogenetics Industry Outlook

North America Molecular Cytogenetics Market Outlook

U.S. Molecular Cytogenetics Market Outlook

Canada Molecular Cytogenetics Market Outlook

Europe Molecular Cytogenetics Market Outlook

Germany Molecular Cytogenetics Market Outlook

France Molecular Cytogenetics Market Outlook

Italy Molecular Cytogenetics Market Outlook

Spain Molecular Cytogenetics Market Outlook

UK Molecular Cytogenetics Market Outlook

Asia Pacific Molecular Cytogenetics Market Outlook

Japan Molecular Cytogenetics Market Outlook

China Molecular Cytogenetics Market Outlook

Latin America Molecular Cytogenetics Market Outlook

Mexico Molecular Cytogenetics Market Outlook

Brazil Molecular Cytogenetics Market Outlook

MEA Molecular Cytogenetics Market Outlook

South Africa Molecular Cytogenetics Market Outlook

Saudi Arabia molecular cytogenetics market highlights

The Saudi Arabia molecular cytogenetics market generated a revenue of USD 10.5 million in 2020 and is expected to reach USD 22.0 million by 2028.
The Saudi Arabia market is expected to grow at a CAGR of 9.7% from 2021 to 2028.
In terms of segment, oncology was the largest revenue generating application in 2020.
Personalized Medicine is the most lucrative application segment registering the fastest growth during the forecast period.

Molecular cytogenetics market data book summary

Market revenue in 2020	USD 10.5 million
Market revenue in 2028	USD 22.0 million
Growth rate	9.7% (CAGR from 2020 to 2028)
Largest segment	Oncology
Fastest growing segment	Personalized Medicine
Historical data	2018 - 2019
Base year	2020
Forecast period	2021 - 2028
Quantitative units	Revenue in USD million
Market segmentation	Genetic Disorders, Oncology, Personalized Medicine, Other Applications
Key market players worldwide	Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc

Other key industry trends

In terms of revenue, Saudi Arabia accounted for 0.6% of the global molecular cytogenetics market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
In Middle East & Africa, Saudi Arabia molecular cytogenetics market is projected to lead the regional market in terms of revenue in 2028.
South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 14.8 million by 2028.

Key Regions: U.S. , UK , Japan , Brazil , Canada

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Molecular Cytogenetics Market Scope

Molecular cytogenetics market segmentation & scope

Molecular Cytogenetics Market Companies

Name	Profile	# Employees	HQ	Website

Saudi Arabia molecular cytogenetics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.

Oncology was the largest segment with a revenue share of 39.05% in 2020. Horizon Databook has segmented the Saudi Arabia molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other applications covering the revenue growth of each sub-segment from 2018 to 2028.

In Saudi Arabia, the biotechnology industry has witnessed rapid growth since the past few years, which is anticipated to continue in the near future. Several biotechnology companies are inclined to the Saudi Arabian market and making continuous efforts through partnerships with local healthcare companies to enter the market.

For instance, in May 2021, Euformatics entered into a distribution partnership with Illumina’s distributor in Saudi Arabia AI Jeel Medical and Trading Co. This agreement covers Euformatics’ whole product portfolio to offer NGS test validation, quality control, and various interpretation software to laboratories and hospitals in the country.

Furthermore, high unmet clinical needs, rise in disposable incomes, and presence of well-established genomic research centers create an opportunity for growth in the molecular cytogenetics market. For example, the Human Cancer Genomic Research (HCGR) is developing a novel diagnostic and therapeutic strategy aimed at improving the management of cancer.

Reasons to subscribe to Saudi Arabia molecular cytogenetics market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia molecular cytogenetics market databook

Our clientele includes a mix of molecular cytogenetics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia molecular cytogenetics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia molecular cytogenetics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.